[Controversies in therapy of malignant lymphomas]

Internist (Berl). 1994 Apr;35(4):313-22.

[Article in German]

Authors

V Diehl¹, A Engert

Affiliation

¹ Medizinische Universitätsklinik I, Köln.

PMID: 8200756

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Clinical Trials as Topic
Combined Modality Therapy
Hodgkin Disease / mortality
Hodgkin Disease / pathology
Hodgkin Disease / therapy*
Humans
Lymphoma, Non-Hodgkin / mortality
Lymphoma, Non-Hodgkin / pathology
Lymphoma, Non-Hodgkin / therapy*
Neoplasm Staging
Survival Rate